ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,435Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 98

$556K Total Retail Price of All Prescriptions

Rank: 22 out of 98

243 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

25% of this provider’s 243 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

9% of this provider’s 243 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 10,034 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 34.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 908 902 1 1
TRAZODONE HCL 440 427 2 9
LISINOPRIL 439 344 3 3
SIMVASTATIN 427 419 4 2
AMLODIPINE BESYLATE 392 355 5 7
FUROSEMIDE 367 344 6 4
CITALOPRAM HBR 346 337 7 10
METOPROLOL TARTRATE 323 318 8 8
DONEPEZIL HCL 319 318 9 12
LEVOTHYROXINE SODIUM 303 283 10 5
MIRTAZAPINE 267 267 11 11
OXYCODONE HCL 267 55 S2 11 61
GABAPENTIN 227 173 13 13
DIVALPROEX SODIUM 192 192 14 22
NAMENDA 177 177 15 18
OMEPRAZOLE 166 139 16 6
SERTRALINE HCL 156 135 17 19
OLANZAPINE 151 141 18 24
TAMSULOSIN HCL 136 126 19 25
POTASSIUM CHLORIDE 133 133 20 21
OXYCODONE-ACETAMINOPHEN 126 55 S2 21 78
ATENOLOL 122 122 22 14
ATORVASTATIN CALCIUM 120 114 23 20
TRAMADOL HCL 114 114 24 26
METOPROLOL SUCCINATE 105 92 25 16
QUETIAPINE FUMARATE 103 95 26 23
METFORMIN HCL 100 84 27 15
CARBIDOPA-LEVODOPA 97 90 28 44
FINASTERIDE 94 84 29 49
OXYCODONE HCL-ACETAMINOPHEN 93 0 S2 30 241
HYDROCHLOROTHIAZIDE 91 65 31 17
PANTOPRAZOLE SODIUM 85 71 32 42
DILTIAZEM 24HR CD 84 81 33 83
BACLOFEN 84 66 33 59
CYMBALTA 77 66 35 47
ALENDRONATE SODIUM 74 74 36 30
POLYETHYLENE GLYCOL 3350 66 58 37 33
LIDODERM 65 65 38 29
RISPERIDONE 65 63 38 27
ISOSORBIDE MONONITRATE ER 60 53 40 36
LANTUS 55 50 41 28
CLOPIDOGREL 55 55 41 50
FAMOTIDINE 54 46 43 80
ZOLPIDEM TARTRATE 53 17 44 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 7, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.